Help us fund research to slow, stop or reverse Parkinson’s
No one knows for sure, but world-wide around 10 million people have Parkinson's. Currently the only treatments available are symptomatic i.e. they ease symptoms on a day by day basis but none of them slow the neurological decline of Parkinson's on a year by year basis. Levodopa, introduced as a symptomatic treatment in the 1960's, was a game-changer in that it transformed the day to day management of the condition.
Now, some fifty years on, new understanding about the nature of the condition, plus attempts to match a range of innovative therapies to the emerging science is finally starting to change prospects for people with Parkinson's.
It is through understanding more about how people contract Parkinson's that we can open up new avenues of research and focus our efforts to find a cure with more accuracy.Read more
Since the formation of the research committee in 2009, CPT has supported numerous lines of investigation contributing to the development of potential new treatments moving towards clinical trial.Read more
Read the latest Parkinson's science and research news here.Read more